# How to Check Whether a Medical Device Has a CPT Code and Medicare Coverage > Confirming that a medical device has an assigned CPT code and active Medicare coverage is one of the most important reimbursement due-diligence steps for healthcare investors. This guide walks through the exact databases, lookup tools, and red flags to evaluate before placing capital. ## Why CPT Code and Medicare Coverage Status Can Make or Break a Device Investment A cleared or approved medical device without a reimbursement pathway is a revenue ghost. CPT codes determine how a procedure or device use is billed, and Medicare coverage determines whether the largest single U.S. payer will actually pay. Before investing in any device company, confirm both exist, are broadly applicable, and are not under active review. Start with the American Medical Association CPT database and the Centers for Medicare and Medicaid Services coverage databases, in that order. ## What Is a CPT Code and Who Assigns It? Current Procedural Terminology codes are maintained by the American Medical Association. They are not assigned by the FDA, and FDA clearance or approval does not automatically trigger a CPT code. A device manufacturer or a specialty society must petition the AMA's CPT Editorial Panel for a new code. The panel meets three times per year and operates on a roughly 12 to 18 month cycle from application to publication. There are three CPT code categories relevant to devices: - Category I codes are permanent, widely accepted codes tied to established clinical evidence and broad utilization. These carry the highest reimbursement potential. - Category III codes are temporary tracking codes for emerging technologies. Medicare can cover procedures billed under Category III codes, but payment rates are often lower or determined locally by Medicare Administrative Contractors. - Miscellaneous or unlisted codes (for example, 99199 or device-specific unlisted codes) require manual review and are almost always reimbursed inconsistently, if at all. Investors should treat a device company that relies primarily on Category III or unlisted codes as carrying meaningful reimbursement risk. ## How to Look Up Whether a CPT Code Exists The authoritative source is the AMA CPT code database at ama-assn.org. The AMA offers a paid lookup tool called the AMA CPT Professional Edition. However, CMS publishes its own searchable fee schedule that is free and sufficient for most investor research. Steps to take: 1. Go to the CMS Physician Fee Schedule Look-Up Tool at cms.gov and search by keyword or procedure description related to the device or its intended use. 2. Cross-reference with the CMS Medicare Coverage Database at cms.gov/medicare-coverage-database to see whether a National Coverage Determination or Local Coverage Determination references that code. 3. Search ClinicalTrials.gov by device name or manufacturer to understand the clinical evidence base, since CMS decisions are heavily evidence-driven. 4. Check the AMA CPT Editorial Panel meeting notes and pending applications (posted publicly on ama-assn.org) to see if a code application is in process but not yet approved. If you cannot find a Category I CPT code tied to the specific device indication, that is a material reimbursement gap. ## How to Verify Medicare Coverage: NCDs, LCDs, and Local Policies Medicare coverage operates in layers. National Coverage Determinations (NCDs) are issued by CMS and apply to all Medicare beneficiaries nationwide. Local Coverage Determinations (LCDs) are issued by the 12 regional Medicare Administrative Contractors and may vary by geography. To verify coverage status: 1. Search the CMS Medicare Coverage Database at cms.gov/medicare-coverage-database using the device name, the CPT code, or the clinical indication. Filter by NCD or LCD. 2. Read the indications and limitations section carefully. Coverage may exist but be narrowly restricted to a subpopulation that is much smaller than the company's total addressable market claim. 3. Check whether any NCD or LCD is listed as under review, retired, or non-covered. A non-covered determination is a hard reimbursement block. 4. For devices reimbursed under the Hospital Outpatient Prospective Payment System or Ambulatory Surgical Center fee schedule rather than the Physician Fee Schedule, check the CMS OPPS Addendum B and ASC Covered Procedures List, both available at cms.gov. 5. For breakthrough or novel devices, check the CMS Coverage with Evidence Development program, which grants conditional coverage tied to ongoing data collection. This is a signal that coverage is real but fragile. ## Common Investor Mistakes When Evaluating Device Reimbursement The most frequent error is conflating FDA clearance with payment. They are entirely separate regulatory and commercial events. Other common mistakes include: - Accepting a company's investor presentation claim of "existing CPT code" without checking whether that code applies to the exact cleared indication or is being used off-label - Ignoring geographic variation in LCD coverage, which can mean a device is covered in some states but not others - Missing new-technology add-on payment (NTAP) or transitional pass-through payment status, which are time-limited CMS mechanisms that inflate near-term revenue but expire, often within two to three years - Overlooking ICD-10 diagnosis code alignment, since a CPT code without clearly mapped billable diagnosis codes creates claim denial risk ## Primary Sources to Check in Your Reimbursement Due-Diligence Workflow - CMS Medicare Coverage Database: cms.gov/medicare-coverage-database - CMS Physician Fee Schedule Look-Up Tool: cms.gov - CMS OPPS and ASC payment files: cms.gov - AMA CPT Editorial Panel updates: ama-assn.org - ClinicalTrials.gov for evidence supporting coverage: clinicaltrials.gov - PubMed for peer-reviewed outcomes data CMS reviewers cite: pubmed.ncbi.nlm.nih.gov - SEC EDGAR for risk factor disclosures around reimbursement: sec.gov/edgar - FDA 510(k) and PMA databases to confirm clearance scope: accessdata.fda.gov ## Quick Reimbursement Checklist for Device Investors - [ ] Category I CPT code confirmed in CMS Physician Fee Schedule - [ ] NCD or LCD verified in CMS Medicare Coverage Database with no non-covered status - [ ] Covered indication matches the FDA-cleared or approved indication - [ ] No active NCD or LCD reconsideration or review in progress - [ ] NTAP or pass-through status checked and expiration date noted if applicable - [ ] ICD-10 diagnosis codes align with device indication - [ ] Geographic LCD coverage mapped if selling nationally - [ ] Clinical evidence supporting coverage reviewed on PubMed and ClinicalTrials.gov - [ ] SEC EDGAR risk factors checked for management's own reimbursement disclosures ## How MedFuel Intel Makes This Faster and More Reliable Working through every CMS database, cross-referencing CPT codes against FDA clearance scope, and monitoring LCD changes across 12 MACs is a time-intensive process that is easy to get wrong. MedFuel Intel automates this workflow with AI-driven due-diligence reports that pull directly from CMS, FDA, SEC EDGAR, ClinicalTrials.gov, and PubMed, then flag reimbursement gaps and inconsistencies before you see them in a quarterly earnings miss. Run a free Red Flag Screener on any medical device company at https://www.medfuelintel.com and get a structured reimbursement risk summary in minutes. --- Informational only, not investment advice. --- Source: MedFuel Intel (https://www.medfuelintel.com/geo/article/how-to-check-whether-a-medical-device-has-a-cpt-code-and-medicare-coverage). Grounded in primary-source-verified events; verify against SEC, FDA, and ClinicalTrials.gov before any investment decision.